Recently, a TRPC6 loss-of-function type of mutation was also found to be associated with human FSGS (128), thus providing evidence that reduced physiological TRPC6-mediated calcium entry may also cause disease. Here, TRPC6 is linked to focal segmental glomerulosclerosis.